Group One Trading
IMDX

Group One Trading’s Insight Molecular Diagnostics IMDX Stock Holding History

Group One Trading’s Portfolio IMDX Stock Details IMDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-1
Closed -$9 – 8034
2023
Q1 		$9 Hold
1
– – ﹤0.01% 7093
2022
Q4 		$8 Sell
1
-130
-99% -$1.43K ﹤0.01% 7120
2022
Q3 		$2K Sell
131
-15
-10% -$260 ﹤0.01% 7180
2022
Q2 		$3K Sell
146
-162
-53% -$3.68K ﹤0.01% 7314
2022
Q1 		$9K Sell
308
-100
-25% -$3.2K ﹤0.01% 7205
2021
Q4 		$18K Buy
408
+71
+21% +$4.08K ﹤0.01% 7035
2021
Q3 		$24K Buy
337
+122
+57% +$11.2K ﹤0.01% 7066
2021
Q2 		$25K Sell
215
-400
-65% -$39.1K ﹤0.01% 7055
2021
Q1 		$64K Buy
615
+360
+141% +$34.2K ﹤0.01% 6047
2020
Q4 		$12K Buy
255
+250
+5,000% +$9.17K ﹤0.01% 5725
2020
Q3 		$0 Sell
5
-70
-93% -$2.01K ﹤0.01% 6410
2020
Q2 		$3K Buy
+75
New +$3.87K ﹤0.01% 5496
2020
Q1 		– Sell
-55
Closed -$2K – 5606
2019
Q4 		$2K Sell
55
-100
-65% -$3.61K ﹤0.01% 4909
2019
Q3 		$7K Hold
155
– – ﹤0.01% 4684
2019
Q2 		$8K Buy
+155
New +$12.9K ﹤0.01% 4492
2019
Q1 		– Sell
-1
Closed – – 5203
2018
Q4 		$0 Hold
1
– – ﹤0.01% 5243
2018
Q3 		$0 Hold
1
– – ﹤0.01% 5492
2018
Q2 		$0 Hold
1
– – ﹤0.01% 5353
2018
Q1 		$0 Hold
1
– – ﹤0.01% 5181
2017
Q4 		$0 Hold
1
– – ﹤0.01% 5104
2017
Q3 		$0 Hold
1
– – ﹤0.01% 5051
2017
Q2 		$0 Hold
1
– – ﹤0.01% 4973
2017
Q1 		$0 Hold
1
– – ﹤0.01% 4895
2016
Q4 		$0 Sell
1
-2
-67% -$220 ﹤0.01% 4703
2016
Q3 		$0 Sell
3
-20
-87% -$1.61K ﹤0.01% 4786
2016
Q2 		$2K Hold
23
– – ﹤0.01% 4432
2016
Q1 		$2K Buy
+23
New +$2.04K ﹤0.01% 4380

Other funds holding IMDX

BC
Broadwood Capital New York $1.42B AUM 34.72% 1-Year Est. Return
AIC
AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return
PVI
Pura Vida Investments New York $14.9M AUM 38.76% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
HCM
Heights Capital Management San Francisco, California $359M AUM 7.93% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
FIA
FNY Investment Advisers New York $278M AUM 98.95% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM

Group One Trading's IMDX Position: Q2 2023 in Review

Group One Trading sold out of Insight Molecular Diagnostics (IMDX) in Q2 2023, closing a stake of 1 share — an estimated $9 sold.

Group One Trading first reported a position in IMDX in Q1 2016 and held it in 27 quarters. The position peaked at $64K in Q1 2021. 47 funds tracked by Wall St. Rank hold IMDX as of Q2 2023.

  • Group One Trading reported no remaining Insight Molecular Diagnostics position as of Q2 2023 after selling out during the quarter.
  • Group One Trading sold 1 Insight Molecular Diagnostics share in Q2 2023, an estimated $9.
  • Group One Trading first reported a position in Insight Molecular Diagnostics in Q1 2016 and held it in 27 quarters.
  • Group One Trading's Insight Molecular Diagnostics position peaked at $64K in Q1 2021.
  • 47 funds tracked by Wall St. Rank held Insight Molecular Diagnostics as of Q2 2023.

Based on Group One Trading's 13F filing for Q2 2023, filed 9 Aug 2023.